ERBB2 and breast cancer: For BC, FDA-approved IVD devices include testing for BRCA 1, BRCA2, and PIK3CA mutations, HER2 gene amplification, and protein expression of HER-2, PD-L1, and Ki67 (Supplementary file S1, Table S2).